Rationale and design of the IRON‐CRT trial: effect of intravenous ferric carboxymaltose on reverse remodelling following cardiac resynchronization therapy
In: ESC Heart Failure, Jg. 6 (2019-09-28), Heft 6, S. 1208-1215
academicJournal
Zugriff:
Titel: |
Rationale and design of the IRON‐CRT trial: effect of intravenous ferric carboxymaltose on reverse remodelling following cardiac resynchronization therapy
|
---|---|
Autor/in / Beteiligte Person: | Martens, Pieter ; Dupont, Matthias ; Dauw, Jeroen ; Somers, Frauke ; Herbots, Lieven ; Timmermans, Philippe ; Verwerft, Jan ; Mullens, Wilfried |
Zeitschrift: | ESC Heart Failure, Jg. 6 (2019-09-28), Heft 6, S. 1208-1215 |
Veröffentlichung: | 2019 |
Medientyp: | academicJournal |
DOI: | 10.1002/ehf2.12503 |
Sonstiges: |
|